SRT Versus SRT+ADT in Prostate Cancer

NCT05019846 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Triptorelin Embonate
DRUG: Bicalutamide 50 mg

Sponsor

Marco Lorenzo Bonu

Collaborators

[object Object]